SUMGEN
Founded Year
2015Stage
Series B - II | AliveTotal Raised
$71.02MLast Raised
$31.38M | 2 yrs agoAbout SUMGEN
SUMGEN operates as an innovation-driven biopharmaceutical company. It develops and commercializes innovative antibody drugs for major diseases such as malignant tumors. The company was founded in 2015 and is based in Hangzhou, China.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
SUMGEN Patents
SUMGEN has filed 7 patents.
The 3 most popular patent topics include:
- Clusters of differentiation
- Immunology
- Monoclonal antibodies
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/11/2019 | 8/1/2023 | Clusters of differentiation, Monoclonal antibodies, Immunology, Transcription factors, Immune system | Grant |
Application Date | 2/11/2019 |
|---|---|
Grant Date | 8/1/2023 |
Title | |
Related Topics | Clusters of differentiation, Monoclonal antibodies, Immunology, Transcription factors, Immune system |
Status | Grant |
Latest SUMGEN News
Oct 1, 2020
publication date: Oct 1, 2020 Sumgen Biotech of Hangzhou completed a $32 million Series B funding round to advance its portfolio of novel immunotherapy antibodies. The round was led by Addor Capital and co-led by Cowin Capital and Sinowisdom Investment. The proceeds will be used to fund clinical trials of the company's pipeline of ten oncology mAbs and construction of an antibody production facility in Hangzhou Share this with colleagues: Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today? If you are already a subscriber, please login. If you believe you should have received this message in error, please contact us .
SUMGEN Frequently Asked Questions (FAQ)
When was SUMGEN founded?
SUMGEN was founded in 2015.
Where is SUMGEN's headquarters?
SUMGEN's headquarters is located at Room 101, Floor 1, Building C, Building 2, No. 688, Bin'an Road, Changhe Street, Hangzhou.
What is SUMGEN's latest funding round?
SUMGEN's latest funding round is Series B - II.
How much did SUMGEN raise?
SUMGEN raised a total of $71.02M.
Who are the investors of SUMGEN?
Investors of SUMGEN include Addor Capital, ZheShang Venture Capital, Junchuan Capital, Hankang Equity Investment Management, Wanhui Capital and 10 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
